Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SomaLogic, Inc. (SLGCW)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
0.9400+0.0300 (+3.30%)
At close: 11:42AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.9100
Open3.0800
Bid2.3400 x 1000
Ask5.6200 x 1000
Day's Range0.7970 - 0.9447
52 Week Range0.7970 - 0.9447
Volume885
Avg. VolumeN/A
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.4040
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for SLGCW

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • GlobeNewswire

      SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay

      Brings differentiated miniaturization technology, scientific and engineering expertise, and enhanced ease-of-use capabilities to SomaLogic’s platform while expanding footprint to San Diego, CA BOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix provides deep scientific and engineering exper

    • GlobeNewswire

      SomaLogic to Announce Second Quarter 2022 Financial Results

      BOULDER, Colo. , July 25, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022. Company management will host a corresponding audio webcast beginning at 4:30 p.m. ET. Those interested in listening to the audio webcast should register online here. Participants are encouraged to register more than 15 minutes before the start of the ca

    • Simply Wall St.

      What Type Of Shareholders Own The Most Number of SomaLogic, Inc. (NASDAQ:SLGC) Shares?

      The big shareholder groups in SomaLogic, Inc. ( NASDAQ:SLGC ) have power over the company. Large companies usually have...

    Advertisement
    Advertisement